Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Some Pointers From The US FDA On How To Conduct Better Out-Of-Spec Investigations
For Starters, Re-Read The 2006 OOS Guidance
Oct 08 2019
•
By
Joanne S. Eglovitch
FDA Says Industry Not Hitting The Mark In OOS Investigations • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance